## Abstract The development over time of antibodies to human papillomavirus type 6 (HPV 6) was studied prospectively in a group of 26 condyloma patients receiving multiple treatments, as well as in 17 healthy subjects with a new HPV 6 infection. The condyloma patients provided serum samples during
Antibodies against human papillomavirus type 6 capsids are elevated in men with previous condylomas
✍ Scribed by ARNE WIKSTRÖM; CARINA EKLUND; GEO VON KROGH; PETER LIDBRINK; JOAKIM DILLNER
- Book ID
- 111277750
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 424 KB
- Volume
- 105
- Category
- Article
- ISSN
- 0365-5555
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Human papillomavirus 6 (HPV 6) causes benign condylomata. As a model for HPV vaccine development, we tested a HPV 6 DNA vaccine candidate, constructed by subcloning the major capsid protein (L1) gene into an expression plasmid having the cytomegalovirus promoter, for its immunogenicity in BALB/c mic
## Abstract Human papillomavirus (HPV) infection is associated with cervical cancer. The E2 and E1 papillomavirus proteins are expressed at the early stage of infection and regulate DNA replication. The E2 protein activates and represses transcription from different HPVs promoters. At some stage wh
Human papillomaviruses (HPVs) have been recognized as an essential pathogenic factor in anogenital cancer. HPV DNA has also been found in a subgroup of head-and-neck squamous-cell carcinomas (HNSCCs), and a causative role of the virus in the development of these tumors has been suggested by the conc